Clifford Swan Investment Counsel LLC / EW
Clifford Swan Investment Counsel LLC’s Edwards Lifesciences Corp Position
Does Clifford Swan Investment Counsel LLC own Edwards Lifesciences Corp (EW)? Yes — 250.5K shares worth $20M (+0.68% of its 13F portfolio) as of Q1 2026, down from 251.6K shares the prior filed quarter.
Position Value
$20M
Q1 2026
Shares
250.5K
% of Portfolio
+0.68%
Quarters Held
30
currently held
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 250.5K | $20M | +0.68% |
| Q4 2025 | 251.6K | $21M | +0.71% |
| Q3 2025 | 253.3K | $20M | +0.66% |
| Q2 2025 | 253.4K | $20M | +0.70% |
| Q1 2025 | 253.4K | $18M | +0.68% |
| Q4 2024 | 253.6K | $19M | +0.68% |
| Q3 2024 | 254.4K | $17M | +0.60% |
| Q2 2024 | 239.4K | $22M | +0.83% |
| Q1 2024 | 240.0K | $23M | +0.85% |
| Q4 2023 | 253.3K | $19M | +0.75% |
| Q3 2023 | 254.3K | $18M | +0.74% |
| Q2 2023 | 255.5K | $24M | +0.97% |
| Q1 2023 | 255.8K | $21M | +0.89% |
| Q4 2022 | 256.3K | $19M | +0.83% |
| Q3 2022 | 261.8K | $22M | +1.02% |
| Q2 2022 | 266.4K | $25M | +1.10% |
| Q1 2022 | 267.5K | $31M | +1.17% |
| Q4 2021 | 277.4K | $36M | +1.26% |
| Q3 2021 | 280.6K | $32M | +1.19% |
| Q2 2021 | 288.3K | $33M | +1.25% |
| Q1 2021 | 292.8K | $24M | +1.01% |
| Q4 2020 | 297.5K | $27M | +1.18% |
| Q3 2020 | 310.1K | $25M | +1.19% |
| Q2 2020 | 311.4K | $22M | +1.11% |
| Q1 2020 | 104.8K | $20M | +1.20% |
| Q4 2019 | 105.9K | $25M | +1.19% |
| Q3 2019 | 109.9K | $24M | +1.25% |
| Q2 2019 | 111.3K | $21M | +1.08% |
| Q1 2019 | 112.1K | $21M | +1.15% |
| Q4 2018 | 113.2K | $17M | +1.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Clifford Swan Investment Counsel LLC’s full portfolio or all institutional holders of EW.